Abstract #0763
In-vivo proton MR spectroscopic imaging of the human brain gliomas at 9.4 Tesla: evaluation of metabolite coordinates
Grzegorz L. Chadzynski 1,2 , Gisela Hagberg 1,2 , Jonas Bause 2 , G. Shajan 2 , Sotirios Bisdas 3 , Rolf Pohmann 2 , and Klaus Scheffler 1,2
1
Dept. Biomedical Magnetic Resonance,
University of Tuebingen, Tuebingen, Germany,
2
Dept.
High-field Magnetic Resonance, Max Planck Institute for
Biological Cybernetics, Tuebingen, Germany,
3
Dept.
Diagnostic and Interventional Neuroradiology, University
of Tuebingen, Tuebingen, Germany
Recently it was demonstrated that the advantages of
ultra-high field MR spectroscopic imaging (MRSI), namely
the better signal-to-noise ratio and the improved
spectral resolution, can be useful in clinical
applications. Studies conducted at lower field strengths
(below 3T) have shown that an evaluation with the
Orthonormal Discriminant Vector method (ODV) enables
differentiation between low (WHO grade II and III) and
high grade (WHO grade IV) human brain tumors. The aim of
this study was to verify the usefulness of the ODV
method in assessing human brain tumor spectra measured
with MRSI at a field strength of 9.4T.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
